BamSEC and AlphaSense Join Forces
Learn More

CV Therapeutics Inc

Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 3 pages Third Amendment to First Amended and Restated Rights Agreement
12/34/56
EX-4.1
from 8-K 8 pages Second Amendment to First Amended and Restated Rights Agreement
12/34/56
EX-4.1
from 8-K 1 page First Amendment to First Amended and Restated Rights Agreement
12/34/56
EX-4.1
from S-8 7 pages CV Therapeutics, Inc. Amended and Restated Certificate of Incorporation (Filed Pursuant to SEC. 242 & 245) of CV Therapeutics, Inc
12/34/56
EX-4.11
from 10-K 11 pages CV Therapeutics, Inc. Warrant to Purchase Shares of Common Stock
12/34/56
EX-4.10
from 10-K 12 pages CV Therapeutics, Inc. Warrant to Purchase Shares of Common Stock
12/34/56
EX-4.2
from 8-K 13 pages Trustee’s Certificate of Authentication
12/34/56
EX-4.1
from 8-K 82 pages CV Therapeutics, Inc. as Issuer and Wells Fargo Bank, National Association as Trustee Indenture Dated as of July 1, 2005 3¼% Senior Subordinated Convertible Notes Due 2013
12/34/56
EX-4.11
from S-8 3 pages Notice of Grant of Stock Options and Stock Option Terms and Conditions
12/34/56
EX-4.10
from S-8 4 pages CV Therapeutics, Inc. Stock Appreciation Rights Agreement Grant Notice
12/34/56
EX-4.9
from S-8 4 pages CV Therapeutics, Inc. Restricted Stock Unit Agreement Grant Notice
12/34/56
EX-4.2
from 10-Q 16 pages Unless This Certificate Is Presented by an Authorized Representative of the Depository Trust Company (“Dtc”) to CV Therapeutics, Inc. (Or Its Successor) or Its Agent for Registration of Transfer, Exchange, Conversion or Payment, and Any Certificate Issued Is Registered in the Name of Cede & Co. or of Such Other Entity as Is Requested by an Authorized Representative of Dtc (And Any Payment Hereon Is Made to Cede & Co. or to Such Other Entity as Is Requested by an Authorized Representative of Dtc), Any Transfer, Pledge or Other Use Hereof for Value or Otherwise by or to Any Person Is Wrongful Since the Registered Owner Hereof, Cede & Co., Has an Interest Herein
12/34/56
EX-4.1
from 10-Q 91 pages CV Therapeutics, Inc. as Issuer and Wells Fargo Bank, National Association as Trustee Indenture Dated as of May 18, 2004 2¾% Senior Subordinated Convertible Notes Due 2012
12/34/56
EX-4.5
from 10-K 2 pages Amendment
12/34/56
EX-4.6
from S-8 9 pages CV Therapeutics, Inc. Employee Stock Purchase Plan
12/34/56
EX-4.3
from 10-Q 15 pages Unless This Certificate Is Presented by an Authorized Representative of the Depository Trust Company (“Dtc”) to CV Therapeutics, Inc. (Or Its Successor) or Its Agent for Registration of Transfer, Exchange, Conversion or Payment, and Any Certificate Issued Is Registered in the Name of Cede & Co. or of Such Other Entity as Is Requested by an Authorized Representative of Dtc (And Any Payment Hereon Is Made to Cede & Co. or to Such Other Entity as Is Requested by an Authorized Representative of Dtc), Any Transfer, Pledge or Other Use Hereof for Value or Otherwise by or to Any Person Is Wrongful Since the Registered Owner Hereof, Cede & Co., Has an Interest Herein
12/34/56
EX-4.2
from 10-Q 85 pages CV Therapeutics, Inc. as Issuer and Wells Fargo Bank Minnesota, National Association as Trustee Indenture Dated as of June 18, 2003 $100,000,000 2.0% Senior Subordinated Convertible Debentures Due 2023
12/34/56
EX-4.1
from 8-K 12 pages CV Therapeutics, Inc. Warrant to Purchase Shares of Common Stock
12/34/56
EX-4.1
from 10-Q 12 pages CV Therapeutics, Inc. Warrant to Purchase Shares of Common Stock
12/34/56
EX-4.1
from S-8 ~10 pages Indenture or similar
12/34/56